Genomic Predictors of Decitabine Response in AML/MDS
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 05 Sep 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 18 Aug 2017 Planned End Date changed from 30 Apr 2018 to 23 Jun 2018.